Healthcare -
Biotechnology - NASDAQ - US
$ 0.26
3.09 %
$ 16.8 M
Market Cap
-0.42
P/E
GLYC - CASH FROM OPERATIONS
Cash from Operations GLYC - GlycoMimetics, Inc.
-34.9 M
LAST VALUE
22.11%
2 YEAR CAGR
4.25%
5 YEAR CAGR
-8.42%
10 YEAR CAGR